Pfizer
Trade Pfizer 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About PFE
Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases.
PFE Key Statistics
Stock Snapshot
The current Pfizer(PFE) stock price is $27.84, with a market capitalization of 158.68B. The stock trades at a price-to-earnings (P/E) ratio of 36.73 and offers a dividend yield of 6.20%.
On 2026-09-22, Pfizer(PFE) stock traded between a low of $27.50 and a high of $27.99. Shares are currently priced at $27.84, which is +1.3% above the low and -0.5% below the high.
The Pfizer(PFE)'s current trading volume is 15.59M, compared to an average daily volume of 34.37M.
In the last year, Pfizer(PFE) shares hit a 52-week high of $29.21 and a 52-week low of $23.58.
In the last year, Pfizer(PFE) shares hit a 52-week high of $29.21 and a 52-week low of $23.58.
PFE News
Picking a solid dividend stock to own for the long haul isn't necessarily easy. Balancing safety and dividend income can make it challenging to find the right s...
Pfizer (PFE) CEO Albert Bourla is expected to attend President Trump’s September 24 state dinner for Chinese President Xi Jinping, as the leaders seek greater s...
Key Points Dividend payments offer you security in difficult markets -- and extra growth in better times. These pharma companies offer dividend yields that be...
Analyst ratings
61%
of 28 ratingsMore PFE News
Pfizer Inc (PFE) announced an update on their ongoing clinical study. Pfizer Inc. (PFE) is running a phase 3 study called “An interventional efficacy and safet...
Pfizer Inc (PFE) announced an update on their ongoing clinical study. Pfizer Inc. (PFE) has completed a Phase 1 study titled “A PHASE 1, OPEN-LABEL, FIXED SEQU...
Key Points Pfizer has made significant progress in addressing some of its challenges. However, the company still has a rocky road ahead. Launching newer medi...
The U.S. Department of Health and Human Services, HHS, will receive a portion of the increased revenue if Pfizer (PFE) raises its drug prices abroad, Rachel Coh...
Pfizer recently presented at the Morgan Stanley 24th Annual Global Healthcare Conference in New York, with CEO Albert Bourla outlining how the business is handl...
Pfizer (NYSE: PFE) has experienced unprecedented circumstances in the previous decade. Missed AI’s "Act 1"? Act 2 Could Be 15x Bigger. Most investors think the...
Investing Pfizer’s Dividend Yield Is Enormous. But Is the Payout Still Growing? Pfizer has raised its dividend every year for over a decade, then something chan...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.